Multicenter, retrospective registry of isolated atherosclerotic popliteal arteries treated with endovascular revascularization.
Humans
Aged
Popliteal Artery
/ diagnostic imaging
Retrospective Studies
Femoral Artery
Peripheral Arterial Disease
/ diagnosis
Angioplasty, Balloon
/ adverse effects
Treatment Outcome
Atherosclerosis
/ surgery
Endovascular Procedures
/ adverse effects
Registries
Vascular Patency
Coated Materials, Biocompatible
Angioplasty
Drug-coated balloon
Drug-eluting stent
Interwoven nitinol stent
Isolated popliteal artery lesions
Journal
Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
08
01
2023
accepted:
10
05
2023
medline:
27
7
2023
pubmed:
23
5
2023
entrez:
22
5
2023
Statut:
ppublish
Résumé
Isolated atherosclerotic popliteal lesions (IAPLs) have been considered challenging. This study aimed to investigate the efficacy of endovascular therapy (EVT) using the newer devices for IAPLs. This retrospective multicenter registry analyzed patients with lower extremity artery disease having IAPLs who underwent EVT using the newer devices between 2018 and 2021. The primary outcome was primary patency 1 year after EVT. A total of 392 consecutive patients undergoing EVT for IAPLs were enrolled. The Kaplan-Meier analysis showed that the primary patency and the freedom from target lesion revascularization were 80.9% and 87.8% 1 year after EVT, respectively. The multivariate Cox proportional hazards regression analysis showed that the clinical features that were independently associated with restenosis risk were drug-coated balloon (DCB) use for younger age (< 75 years old; adjusted hazard ratio, 3.08 [95% confidence interval 1.08-8.74]; P = 0.035), non-ambulatory status (2.74 [95% confidence interval 1.56-4.81]; P < 0.001), cilostazol use (0.51 [95% confidence interval 0.29-0.88]; P = 0.015), severe calcification (1.86 [95% confidence interval 1.18-2.94]; P = 0.007), and small external elastic membrane (EEM) area measured by intravascular ultrasound (IVUS) (< 30 mm
Identifiants
pubmed: 37217811
doi: 10.1007/s00380-023-02271-8
pii: 10.1007/s00380-023-02271-8
doi:
Substances chimiques
Coated Materials, Biocompatible
0
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1117-1129Informations de copyright
© 2023. Springer Nature Japan KK, part of Springer Nature.
Références
Morley RL, Sharma A, Horsch AD, Hinchliffe RJ (2018) Peripheral artery disease. BMJ 360:j5842
doi: 10.1136/bmj.j5842
pubmed: 29419394
Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, Schroeder H, Prem JT, Holden A, Popma J, Jaff MR, Diaz-Cartelle J, Müller-Hülsbeck S, IMPERIAL Investigators (2018) A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): A randomised, non-inferiority trial. Lancet 392(10157):1541–1551
doi: 10.1016/S0140-6736(18)32262-1
pubmed: 30262332
Iida O, Takahara M, Soga Y, Yamaoka T, Fujihara M, Kawasaki D, Ichihashi S, Kozuki A, Nanto S, Sakata Y, Mano T, CAPSICUM Investigators (2022) 1-Year outcomes of fluoropolymer-based drug-eluting stent in femoropopliteal practice: Predictors of restenosis and aneurysmal degeneration. JACC Cardiovasc Interv 15(6):630–638
doi: 10.1016/j.jcin.2022.01.019
pubmed: 35331454
Laird JA, Schneider PA, Jaff MR, Brodmann M, Zeller T, Metzger DC, Krishnan P, Scheinert D, Micari A, Wang H, Masters M, Tepe G (2019) Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions. Circ Cardiovasc Interv 12(6):e007702
doi: 10.1161/CIRCINTERVENTIONS.118.007702
pubmed: 31195825
Ohki T, Kichikawa K, Yokoi H, Iida O, Yamaoka T, Maeda K, Kanaoka Y (2021) Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery. J Vasc Surg 74(6):1958-1967.e2
doi: 10.1016/j.jvs.2021.05.056
pubmed: 34182032
Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I, ESC Scientific Document Group (2018) 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: The European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39(9):763–816
doi: 10.1093/eurheartj/ehx095
pubmed: 28886620
Troisi N, Saratzis A, Katsogridakis E, Stavroulakis K, Berchiolli R, Zayed H, Torsello G (2023) Different endovascular modalities of treatment for isolated atherosclerotic popliteal artery lesions (EMO-POP) registry. J Vasc Surg 77(1):231-240.e4
doi: 10.1016/j.jvs.2022.07.170
pubmed: 35934215
Dorigo W, Pulli R, Piffaretti G, Castelli P, Griselli F, Dorrucci V, Ferilli F, Ottavi P, De Blasis G, Scalisi L, Monaca V, Battaglia G, Vecchiati E, Casali G, Pratesi C (2012) Results from an Italian multicentric registry comparing heparin-bonded ePTFE graft and autologous saphenous vein in below-knee femoro-popliteal bypasses. J Cardiovasc Surg (Torino) 53(2):187–194
pubmed: 22456641
Gaudin A, Jayet J, Decaix V, Davaine JM, Couture T, Gaudric J, Chiche L, Koskas F (2020) Endarterectomy for isolated atherosclerotic lesions of the popliteal artery. Ann Vasc Surg 66:631–635
doi: 10.1016/j.avsg.2020.01.091
pubmed: 32044342
Brescia AA, Wickers BM, Correa JC, Smeds MR, Jacobs DL (2015) Stenting of femoropopliteal lesions using interwoven nitinol stents. J Vasc Surg 61(6):1472–1478
doi: 10.1016/j.jvs.2015.01.030
pubmed: 25752693
Dias-Neto M, Matschuck M, Bausback Y, Banning-Eichenseher U, Steiner S, Branzan D, Staab H, Varcoe RL, Scheinert D, Schmidt A (2018) Endovascular treatment of severely calcified femoropopliteal lesions using the “pave-and-crack” technique: technical description and 12-month results. J Endovasc Ther 25(3):334–342
doi: 10.1177/1526602818763352
pubmed: 29557221
Horie K, Takahara M, Nakama T, Tanaka A, Tobita K, Hayakawa N, Mori S, Iwata Y, Suzuki K (2022) Retrospective multicenter comparison between Viabahn covered stent-grafts and supera interwoven nitinol stents for endovascular treatment in severely calcified femoropopliteal artery disease: the ARMADILLO study (Adjusted Retrospective coMparison of scAffolDs In caLcified LesiOns). J Endovasc Ther 22: 15266028221124727. https://doi.org/10.1177/15266028221124727 (Epub ahead of print, PMID: 36146948)
Horie K, Tanaka A, Taguri M, Kato S, Inoue N (2018) Impact of prolonged inflation times during plain balloon angioplasty on angiographic dissection in femoropopliteal lesions. J Endovasc Ther 25(6):683–691
doi: 10.1177/1526602818799733
pubmed: 30203701
Miki K, Fujii K, Kawasaki D, Shibuya M, Fukunaga M, Imanaka T, Tamaru H, Sumiyoshi A, Nishimura M, Horimatsu T, Saita T, Okada K, Kimura T, Honda Y, Fitzgerald PJ, Masuyama T, Ishihara M (2016) Intravascular ultrasound-derived stent dimensions as predictors of angiographic restenosis following nitinol stent implantation in the superficial femoral artery. J Endovasc Ther 23(3):424–432
doi: 10.1177/1526602816641669
pubmed: 27044270
Kurata N, Iida O, Asai M, Masuda M, Okamoto S, Ishihara T, Nanto K, Mano T (2020) Factors influencing in-stent occlusion after femoropopliteal artery stent placement with intravascular ultrasound evaluation. J Vasc Interv Radiol 31(2):213–220
doi: 10.1016/j.jvir.2019.08.014
pubmed: 31883937
Fujihara M, Kurata N, Yazu Y, Mori S, Tomoi Y, Horie K, Nakama T, Tsujimura T, Nakata A, Iida O, Sonoda S, Torii S, Ishihara T, Azuma N, Urasawa K, Ohki T, Komori K, Kichikawa K, Yokoi H, Nakamura M (2022) Clinical expert consensus document on standards for lower extremity artery disease of imaging modality from the Japan Endovascular Treatment Conference. Cardiovasc Interv Ther 37(4):597–612
doi: 10.1007/s12928-022-00875-x
pubmed: 35852760
Stoner MC, Calligaro KD, Chaer RA, Dietzek AM, Farber A, Guzman RJ, Hamdan AD, Landry GJ, Yamaguchi DJ, Society for Vascular Surgery (2016) Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Surg 64(1):e1–e21
doi: 10.1016/j.jvs.2016.03.420
pubmed: 27345516
Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, Yamauchi Y, Tobita K, Kozuki A, Fujihara M, Ando K, POPCORN Investigators (2023) Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion. J Am Heart Assoc 12(1):e025677
doi: 10.1161/JAHA.122.025677
pubmed: 36583431
Mori S, Yamauchi Y, Doijiri T, Tobita K, Hishikari K, Honda Y, Tsutsumi M, Kobayashi N, Yamawaki M, Ito Y (2022) Comparison between clinical outcomes of low- and high-dose paclitaxel drug-coated balloon in endovascular therapy for femoropopliteal lesion. Cardiovasc Intervent Radiol. https://doi.org/10.1007/s00270-022-03289-7
doi: 10.1007/s00270-022-03289-7
pubmed: 36316495
Horie K, Takahara M, Nakama T, Tanaka A, Tobita K, Hayakawa N, Mori S, Iwata Y, Suzuki K (2022) Impact of postoperative lumen gain on the reduction of restenosis risk after endovascular treatment using drug-coated balloon for femoropopliteal lesions assessed by intravascular ultrasound. J Atheroscler Thromb. https://doi.org/10.5551/jat.63886
doi: 10.5551/jat.63886
pubmed: 36436877
Krishnan P, Farhan S, Schneider P, Kamran H, Iida O, Brodmann M, Micari A, Sachar R, Urasawa K, Scheinert D, Ando K, Tarricone A, Doros G, Tepe G, Yokoi H, Laird J, Zeller T (2022) Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention. J Am Coll Cardiol 80(13):1241–1250
doi: 10.1016/j.jacc.2022.06.043
pubmed: 36137674
Cui C, Huang X, Liu X, Li W, Lu X, Lu M, Jiang M, Yin M (2017) Endovascular treatment of atherosclerotic popliteal artery disease based on dynamic angiography findings. J Vasc Surg 65(1):82–90
doi: 10.1016/j.jvs.2016.05.087
pubmed: 27498056
Steiner S, Schmidt A, Bausback Y, Piorkowski M, Werner M, Yahiaoui-Doktor M, Banning-Eichenseer U, Scheinert D (2016) Midterm patency after femoropopliteal interventions: a comparison of standard and interwoven nitinol stents and drug-coated balloons in a single-center, propensity score-matched analysis. J Endovasc Ther 23(2):347–355
doi: 10.1177/1526602816628285
pubmed: 26848131